Radnostix, Inc. Reports FY2026 2nd Quarter and Six Months Results – Completes Execution of FDA 483 & Recall Actions, Restores Capsule Inventory, Completes Lucerno Dynamics Asset Acquisition – PR Newswire

Radnostix, Inc. Reports FY2026 2nd Quarter and Six Months Results – Completes Execution of FDA 483 & Recall Actions, Restores Capsule Inventory, Completes Lucerno Dynamics Asset buyout  PR Newswire

Source: news.google.com